Tags: Drug.

Tezosentan is a non-selective ETA and ETB receptor antagonist. It acts as a vasodilator and was designed as a therapy for patients with acute heart failure. Recent studies have shown however that tezosentan does not improve dyspnea or reduce the risk of fatal or nonfatal cardiovascular events.

Tezosentan.png
ATC prefix
none
FDA UNII code
64J9J55263
IUPAC name
N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide
PubChem
151174

Loading...

This page contains content from the copyrighted Wikipedia article "Tezosentan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.